CKPT Investors Have Opportunity to Lead Checkpoint Therapeutics, Inc. Securities Fraud Lawsuit

LOS ANGELES, May 16, 2024 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Checkpoint Therapeutics, Inc. ("Checkpoint" or the "Company") (NASDAQ: CKPT). Class Period: March 10, 2021 – December 15, 2023 Lead Plaintiff Deadline: June 4, 2024 If you wish to serve as lead plaintiff of the Checkpoint lawsuit, you can submit your contact information at www.glancylaw.com/cases/Checkpoint-T ...